COVID-19 Vaccine With Patch Delivery Technology Enters Preclinical Testing at UC Davis
Original Post: ucdavis.edu/coronavirus/news/covid-19-vaccine-patch-delivery-technology-enters-preclinical-testing-uc-davis
Verndari Inc., a biopharmaceutical company, announced today (April 29) that it will begin preclinical testing this week at the University of California, Davis, Mouse Biology Program to evaluate a potential vaccine and delivery system for COVID-19.
Verndari’s VaxiPatch is a single-dose vaccination kit that uses a dermal patch with a metal microneedle array to deliver vaccines. The company states that the technology eliminates the need for refrigeration, facilitates high-volume, automated manufacturing of vaccines and can potentially be self-administered on the subject’s arm.